David Hung, the PRESIDENT AND CEO of $NUVB, bought 300,000 shares of the company on 04-07-2025 for an estimated $487,500. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 0.5%. Following this trade, they now own 58,781,054 shares of this class of $NUVB stock.
$NUVB Insider Trading Activity
$NUVB insiders have traded $NUVB stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $NUVB stock by insiders over the last 6 months:
- DAVID HUNG (PRESIDENT AND CEO) has made 2 purchases buying 500,000 shares for an estimated $820,220 and 0 sales.
- JUNYUAN JERRY WANG (CEO, ANHEART THERAPEUTICS LTD.) sold 56,361 shares for an estimated $162,883
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NUVB Hedge Fund Activity
We have seen 87 institutional investors add shares of $NUVB stock to their portfolio, and 59 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ECOR1 CAPITAL, LLC removed 19,209,643 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $51,097,650
- FMR LLC added 16,046,701 shares (+54.9%) to their portfolio in Q4 2024, for an estimated $42,684,224
- VANGUARD GROUP INC added 4,913,820 shares (+45.4%) to their portfolio in Q4 2024, for an estimated $13,070,761
- LAURION CAPITAL MANAGEMENT LP added 4,900,000 shares (+307.9%) to their portfolio in Q4 2024, for an estimated $13,034,000
- MPM BIOIMPACT LLC added 4,164,178 shares (+inf%) to their portfolio in Q4 2024, for an estimated $11,076,713
- OCTAGON CAPITAL ADVISORS LP removed 2,968,606 shares (-24.4%) from their portfolio in Q4 2024, for an estimated $7,896,491
- BLACKROCK, INC. added 1,567,783 shares (+9.2%) to their portfolio in Q4 2024, for an estimated $4,170,302
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NUVB Analyst Ratings
Wall Street analysts have issued reports on $NUVB in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 01/07/2025
To track analyst ratings and price targets for $NUVB, check out Quiver Quantitative's $NUVB forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
